| Value | ₹10.50 Cr |
|---|---|
| Execution period | August 10, 2026 to August 12, 2026 |
BSE filing, BSE: 543520. Summary written from the filing by ALFA Finder's alert engine.
Global Longlife Hospital and Research Ltd: key numbers
- Share price
- ₹14.45
- Market cap
- ₹15.17 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-1.72 Cr
- P/E (TTM)
- -8.8×Sector 34.9×
- Promoter holding
- 0.02%-22.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Longlife Hospital and Research Ltd
All →Global Longlife Hospital and Research H1 FY27 Results: Net Profit ₹0 Cr
Global Longlife Hospital and Research Ltd reported net profit of ₹0 Cr for H1 FY27.
- Key figure
- Net profit ₹0 Cr
Global Longlife Hospital and Research Annual General Meeting
Asahi Enterprise held its EGM on October 30, 2026, ratifying a CA certificate for its name change. The meeting carried no financial value or business impact.
Global Longlife Hospital and Research Board Meeting Date
Asahi Enterprise (formerly Global Longlife Hospital) schedules a board meeting on 4 November 2026 to approve half-year unaudited results. The trading window stays closed until 48 hours after results are declared.
Global Longlife Hospital and Research Other Announcement
Global Longlife Hospital and Research Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Global Longlife Hospital and Research Annual General Meeting
Asahi Enterprise Limited (formerly Global Longlife Hospital) has scheduled an Extra Ordinary General Meeting for October 30, 2026, to ratify its name change compliance.
Global Longlife Hospital and Research Board Meeting Outcome
Asahi Enterprise Limited will hold an Extra-Ordinary General Meeting on October 30, 2026, to seek member approval for an issuance.
Other promoter selling announcements
All →JK Cement Promoter Selling: ₹0.53 Cr
Promoter group member Kalpana Singhania sold 1,000 JK Cement shares on the NSE on 05-11-2026. Holding fell to 324,296 shares, roughly 0.41%, worth about Rs.0.53 Crore.
- Value
- ₹0.53 Cr
Alivus Life Sciences Promoter Selling
Nirma Limited, a promoter of Alivus Life Sciences, sold 36,80,000 shares (2.99%) in the open market on 6 November 2026. Promoter holding falls from 74.73% to 71.74%.
KPIT Technologies Promoter Selling: ₹0.41 Cr
KPIT Technologies promoter Hemlata Shende sold 8,000 equity shares in an open-market sale on November 4, 2026, reducing her holding to nil. The transaction value is about Rs.0.41 Crore.
- Value
- ₹0.41 Cr
JK Cement Promoter Selling
Promoter Kalpana Singhania sold 1,000 JK Cement shares via open market on 05 November 2026. Holding fell to 324,296 shares, with the stake effectively unchanged at 0.41%.
Jhaveri Credits & Capital Promoter Selling: ₹0 Cr
Promoter group member Bhumit Patel sold 90 shares via BSE market sale for Rs.15,600. Holding fell to 42,076 shares, 0.37 percent.
- Value
- ₹0.00 Cr
Sri Lotus Developers and Realty Promoter Selling: ₹573 Cr
Promoter Anand Kamalnayan Pandit sold 2.39 crore shares via NSE market sale, worth Rs.572.96 Crore. Promoter holding falls from 70.03% to 65.14%.
- Value
- ₹573.0 Cr